Hyderabad, Feb 16 (TNT): The University of Hyderabad (UoH), an Institution of Eminence, and MNJ Institute of Oncology & Regional Cancer Centre, a premier cancer care institution in Hyderabad, have signed a Memorandum of Understanding (MoU) here on Monday to collaborate on advanced research and development in Precision Oncology.
The MoU was signed by Dr. Devesh Nigam, Registrar, UoH, and Dr. G. Joseph Benjamin, Director, MNJ Institute of Oncology & Regional Cancer Centre, in the presence of B. J. Rao, Vice-Chancellor, UoH; Prof. Sabat S.L., R&D Director; Prof. Bramanandam Manavathi, ANRF-PAIR Project Director; Prof. M. Ghanashyam Krishna, Director–Institution of Eminence; Prof. Anand Kondapi, Dean, School of Life Sciences; and Dr. Raghunatha Rao from MNJ, the University said in a release here.
The partnership aims to combine the research and technological expertise of UoH with the clinical experience and patient-care infrastructure of MNJ Institute of Oncology.
While UoH will contribute its strengths in advanced scientific research and emerging technologies, MNJ will provide clinical insights, patient data, and access to its facilities.
The collaboration will focus on personalized medicine, development of new diagnostic and therapeutic technologies, and improving treatment outcomes for cancer patients.
The MoU provides a framework for joint research projects, knowledge exchange, and capacity-building initiatives. It also opens avenues for intellectual property generation and potential commercialization of research outcomes.
On the occasion, Prof. B.J. Rao described the collaboration as a significant step toward translating laboratory research into practical applications that can transform cancer care in India and beyond.
Dr. G. Joseph Benjamin expressed confidence that the partnership would foster innovative solutions in cancer treatment and enhance patient outcomes.
The agreement will remain valid for five years and may be extended or terminated by mutual consent.
The collaboration is expected to contribute substantially to advancements in cancer research and healthcare delivery in India.
TNT TS
Leave a Reply